These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3051516)

  • 1. Effects of acute administration of O,S,S-trimethyl phosphorodithioate on the generation of cellular and humoral immune responses following in vitro stimulation.
    Rodgers KE; Leung N; Ware CF
    Toxicology; 1988 Oct; 51(2-3):241-53. PubMed ID: 3051516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of subacute administration of O,S,S-trimethyl phosphorodithioate on cellular and humoral immune response systems.
    Rodgers KE; Stern ML; Ware CF
    Toxicology; 1989 Feb; 54(2):183-95. PubMed ID: 2784238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of O,S,S-trimethyl phosphorodithioate on immune function.
    Rodgers KE; Leung N; Ware CF; Imamura T
    Toxicology; 1987 Feb; 43(2):201-16. PubMed ID: 3492784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organophosphorus pesticide immunotoxicity: effects of O,O,S-trimethyl phosphorothioate on cellular and humoral immune response systems.
    Rodgers KE; Imamura T; Devens BH
    Immunopharmacology; 1986 Dec; 12(3):193-202. PubMed ID: 3493228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of subchronic treatment with O,O,S-trimethyl phosphorothioate on cellular and humoral immune response systems.
    Rodgers KE; Imamura T; Devens BH
    Toxicol Appl Pharmacol; 1985 Nov; 81(2):310-8. PubMed ID: 3877352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of cellular and humoral immune responses by O,S,S-trimethyl phosphorodithioate, an impurity of commercial malathion.
    Thomas IK; Imamura T
    Toxicology; 1986 Apr; 39(1):1-12. PubMed ID: 3485840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection from O,O,S-trimethyl phosphorothioate-induced immune suppression.
    Rodgers KE; Haviland DL; Ware CF
    Immunopharmacology; 1989; 17(3):131-40. PubMed ID: 2767956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate: generation of suppressive macrophages from treated animals.
    Rodgers KE; Imamura T; Devens BH
    Toxicol Appl Pharmacol; 1987 Apr; 88(2):270-81. PubMed ID: 3494328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive effect of an impurity of malathion: inhibition of murine T- and B-lymphocyte responses by O,O,S-trimethyl phosphorothioate.
    Thomas IK; Imamura T
    Toxicol Appl Pharmacol; 1986 May; 83(3):456-64. PubMed ID: 2939594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cytotoxic T lymphocyte and natural killer cell-mediated lysis by O,S,S,-trimethyl phosphorodithioate is at an early postrecognition step.
    Rodgers KE; Grayson MH; Ware CF
    J Immunol; 1988 Jan; 140(2):564-70. PubMed ID: 3257244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of macrophage protease activity by acute administration of O,O,S trimethyl phosphorothioate.
    Rodgers KE; Ellefson DD
    Agents Actions; 1990 Mar; 29(3-4):277-85. PubMed ID: 2160188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate. I. Characterization of the immune cell population affected.
    Rodgers KE; Imamura T; Devens BH
    Immunopharmacology; 1985 Dec; 10(3):171-80. PubMed ID: 2939039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute administration of O,O,S-trimethyl phosphorothioate on the respiratory burst and phagocytic activity of splenic and peritoneal leukocytes.
    Rodgers KE; Ellefson DD
    Agents Actions; 1988 Jun; 24(1-2):152-60. PubMed ID: 2841830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung injury and delayed toxicity produced by O,S,S-trimethyl phosphorodithioate, an impurity of malathion.
    Konno N; Fukuto TR; Imamura T
    Toxicol Appl Pharmacol; 1984 Sep; 75(2):219-28. PubMed ID: 6474459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate. II. Effect on the ability of murine macrophages to present antigen.
    Rodgers KE; Imamura T; Devens BH
    Immunopharmacology; 1985 Dec; 10(3):181-9. PubMed ID: 3833856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phosphorothionate isomer protects against the pneumotoxicity caused by O,O,S-trimethyl phosphorothioate.
    Gandy J; Imamura T
    Toxicol Appl Pharmacol; 1987 Mar; 87(3):498-508. PubMed ID: 3564023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited immunotoxic potential of technical formulation of the herbicide atrazine (AAtrex) in mice.
    Fournier M; Friborg J; Girard D; Mansour S; Krzystyniak K
    Toxicol Lett; 1992 May; 60(3):263-74. PubMed ID: 1534425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hydroxyproline content and production following treatment of mice with O,S,S-trimethyl phosphorodithioate.
    Kehrer JP; Lee YC
    Toxicol Lett; 1987 Oct; 38(3):321-7. PubMed ID: 3660435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver damage induced in rats by malathion impurities.
    Keadtisuke S; Dheranetra W; Nakatsugawa T; Fukuto TR
    Toxicol Lett; 1990 Jun; 52(1):35-46. PubMed ID: 2356569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of humoral and cellular immunity by soluble mediators after 5-fluorouracil-induced immunosuppression.
    Merluzzi VJ; Last-Barney K; Susskind BM; Faanes RB
    Clin Exp Immunol; 1982 Nov; 50(2):318-26. PubMed ID: 6217933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.